Cited by 102Parkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology ResearchNuclear Receptors and Signaling

Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons

Open access
Steinkellner, Thomas, Zell, Vivien, Farino, Zachary J., Sonders, Mark S., Villeneuve, Michael, Freyberg, Robin J., Przedborski, Serge, Lu, Wei +2 more·2018·Journal of Clinical Investigation

Abstract

Parkinson's disease is characterized by the loss of dopamine (DA) neurons in the substantia nigra pars compacta (SNc). DA neurons in the ventral tegmental area are more resistant to this degeneration than those in the SNc, though the mechanisms for selective resistance or vulnerability remain poorly understood. A key to elucidating these processes may lie within the subset of DA neurons that corelease glutamate and express the vesicular glutamate transporter VGLUT2. Here, we addressed the potential relationship between VGLUT expression and DA neuronal vulnerability by overexpressing VGLUT in DA neurons of flies and mice. In Drosophila, VGLUT overexpression led to loss of select DA neuron populations. Similarly, expression of VGLUT2 specifically in murine SNc DA neurons led to neuronal loss and Parkinsonian behaviors. Other neuronal cell types showed no such sensitivity, suggesting that DA neurons are distinctively vulnerable to VGLUT2 expression. Additionally, most DA neurons expressed VGLUT2 during development, and coexpression of VGLUT2 with DA markers increased following injury in the adult. Finally, conditional deletion of VGLUT2 made DA neurons more susceptible to Parkinsonian neurotoxins. These data suggest that the balance of VGLUT2 expression is a crucial determinant of DA neuron survival. Ultimately, manipulation of this VGLUT2-dependent process may represent an avenue for therapeutic development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci95795

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Vglut2+ dopamine neurons in the substantia nigra pars compacta are particularly resistant to degeneration in toxin models of Parkinson's disease, and VGLUT2 may play a neuroprotective role by inducing a BDNF/TRKB dependent signaling cascade.

    “In toxin models of PD, Vglut2+ DA neurons in the SNc are particularly resistant to degeneration [58,59], and VGLUT2 itself may play a neuroprotective role by inducing a BDNF/TRKB dependent signaling cascade [59].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Steinkellner, T., Zell, V., Farino, Z. J., Sonders, M. S., Villeneuve, M., Freyberg, R. J., Przedborski, S., Lu, W., Freyberg, Z., & Hnasko, T. S.
Affiliations
  • University of California San Diego (US)
  • University of Pittsburgh (US)
  • Columbia University (US)
Venue
Journal of Clinical Investigation
Published
2018-01-16
Volume
128
Issue
2
Pages
774-788
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2783295659
Cited by
102
References
68
Citations by year
2026: 9 · 2025: 14 · 2024: 15 · 2023: 14 · 2022: 6 · 2021: 15 · 2020: 10 · 2019: 12 · 2018: 7
FWCI
7.46
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
Funders
  • NIH-NINDS (NIH-NINDS R21NS087496)
  • Austrian Science Fund (J3656-B24)
  • DOD PRMRP (PR141292)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
VGLUT2, vesicular glutamate transporter, dopaminergic neurons, Parkinson's disease, substantia nigra pars compacta, ventral tegmental area, selective neuronal vulnerability, Drosophila, conditional knockout, neuronal survival, neurodegeneration
MeSH terms
Animals, Disease Models, Animal, Dopamine, Drosophila melanogaster, Female, Humans, Male, Mesencephalon, Neurons, Neurotoxins, Parkinson Disease, Substantia Nigra, Ventral Tegmental Area, Glutamic Acid, Transgenes, Neurodegenerative Diseases, Vesicular Glutamate Transport Protein 2, Mice, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review